Study Overview
Sex: Female
Age: 18 Years and older (Adult, Older Adult)
No Study Documents
Study Overview
Sex: Female
Age: 18 Years and older (Adult, Older Adult)
No Study Documents
BGB-290-302 ChiCTR1800014643
Active, not recruiting
Maintenance Treatment With BGB-290 Versus Placebo in Participants With Platinum-sensitive Recurrent Ovarian Cancer
Beigene Study ID
BGB-290-302 ChiCTR1800014643
ClinicalTrials.gov ID
China Drug Trials ID
CTR20171666
Sex: Female
Age: 18 Years and older (Adult, Older Adult)
No Study Documents
Sex: Female
Age: 18 Years and older (Adult, Older Adult)
No Study Documents